E-commerce giant and tech company Amazon have received approval from the American drug authority, the Food and Drug Administration (FDA) authority for their new Covid-19 test kit.
The new Covid test facility was developed by subsidiary STS Lab Holdco. The test device is expected to be used by the multinational company for its staff.
A report by The Verge claims that the test equipment that received a green mark from the FDA is expected to be used for its Covid on-site testing programs.
The test device comes with a nasal swab that can be used under the guidance of a medical services provider or as part of a home-made swab where a patient can take their own sample and then send it to a physical lab.
The FDA is authorized, according to the report read, “Amazon plans to use Amazon’s Real-Time RT-PCR Test to detect SARS-CoV-2 (Amazon Test) as part of the overall Coronavirus Disease preparation 2019 (COVID-19) of the company. And response program. “
The agreement also features Amazon’s employee screening program. Naturally, some Amazon employees receive trial meetings around every 14 days. However, the report states that the tests are voluntary.
“Amazon has partnered with a third-party healthcare provider who will issue the necessary orders and individual test orders,” the authority added.
The report said the group began using a modified version of an existing test package that was converted to Amazon test on August 28, 2020. Between the end of September and the beginning of December 2020, run e more than 560,000 samples, according to the agreement.